According to The Insight Partners' research, the Europe Infusion Pumps Market was valued at US$ 3,233.6 Million in 2025 and is expected to reach US$ 5,042.2 Million by 2034, registering a CAGR of 5.1% from 2026 to 2034.
Expansion of home-based and ambulatory infusion therapy and wearable and portable infusion devices are among the critical factors attributed to drive the Europe infusion pumps market.
The expansion of home-based and ambulatory infusion therapy is driven by the shift toward patient-centered care that reduces hospital admissions and improves quality of life for those with chronic conditions. This approach allows patients to receive treatments like antibiotics, chemotherapy, or hydration fluids outside traditional clinical settings, using portable pumps that enable mobility and convenience.
A study in the Journal of Clinical Oncology highlights that home-based chemotherapy infusion can reduce hospital stay lengths by up to 30%, enhancing patient satisfaction without compromising treatment efficacy. Globally, the WHO notes that chronic diseases account for 71% of all deaths, underscoring the need for accessible therapies such as ambulatory infusion for conditions including heart disease and diabetes. In Europe and North America, ambulatory services have grown, with the CDC indicating that 9.5 million adults aged 50 and older received help with daily activities. The National Center for Biotechnology Information reports that nearly 40% of infusion services can be safely provided at home, leading to better adherence and fewer infections. Ambulatory therapy also helps address cost burdens. According to the National Home Infusion Foundation, the industry grew 310% from 2010 to 2019, enabling broader access in developing regions where hospital resources are limited.
On the contrary, product recalls and safety concerns hamper the growth of the Europe infusion pumps market.
Europe Infusion Pumps Market Segmentation Analysis:
- By Product, the Europe Infusion Pumps Market is segmented into IV infusion Pumps, Syringe Infusion Pumps, Volumetric infusion Pumps, Ambulatory Pumps, Patient-Controlled Analgesia (PCA) Pumps, Enteric Feeding Pumps, Disposable Elastomeric Pumps, and Others. The IV infusion Pumps segment is projected to expand at a CAGR of 4.9% during 2026 - 2034.
- By Customer, the Europe Infusion Pumps Market is segmented into Small Hospitals and Nursing Home, Standalone Hospitals, Tertiary Care Hospitals, and Hospital Chain. The Tertiary Care Hospitals segment is projected to expand at a CAGR of 5.7% during 2026 - 2034.
- By End User, the Europe Infusion Pumps Market is segmented into Anaesthesiologists, Critical Care Specialists, and Others. The Anaesthesiologists segment is projected to expand at a CAGR of 5.3% during 2026 - 2034.
By country, the Europe Infusion Pumps Market is categorized into Germany, the United Kingdom, France, Italy, Spain, and the Rest of Europe. Germany is projected to expand at a CAGR of 5.5% during 2026 - 2034.
Key players operating in the Infusion Pumps Market are Terumo Corp, Baxter International Inc, ICU Medical Inc, Fresenius Kabi AG, B. Braun Melsungen AG, Becton Dickinson and Co, Shenzhen Mindray Bio-Medical Electronics Co Ltd, Shenzhen Comen Medical Instruments Co., Ltd., Allied Medical Limited, and Beijing KellyMed Co., Ltd., among others.
- In February 2023, Mindray launched its BeneFusion i Series and u Series infusion systems, featuring high precision, adaptive customization, and extraordinary simplicity for guaranteed levels of medication safety in various clinical settings. The new series will be available in selected countries and regions.
- In July 2023, BD announced that the updated BD Alaris Infusion System had received 510(k) clearance from the US Food and Drug Administration (FDA), which enables both remediation and a return to entire commercial operations for the most comprehensive infusion system available in the US. The clearance covers updated hardware features for point-of-care units, large-volume pumps, syringe pumps, patient-controlled analgesia (PCA) pumps, respiratory monitoring, and auto-identification modules.
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com